CANCELED - Lecture on Fibromyalgia and Migraines to Public April 7

**As of April 5, 2016, this event has been canceled**

The University of Cincinnati Neuroscience Institute and Department of Psychiatry and Behavioral Neuroscience present a lecture series on "Fibromyalgia and Migraines” from 6:30 – 8:30 p.m. Thursday, April 7, in Room 2108 of the Stetson building, 260 Stetson St. 

The program features the following speakers and presentations:

  • "Juvenile Fibromyalgia: What’s New?” by Tracy Ting, MD, assistant professor, UC Department of Pediatrics; Cincinnati Children’s Hospital Medical Center.

  • "Update on Migraine” by Vincent Martin, MD, professor of medicine and the director of the Headache and Facial Pain Program at the University of Cincinnati Neuroscience Institute, who has published extensive research on the topic of migraines.  Martin is the president of the Ohio Headache Association and vice president of the National Headache Foundation.

Presentation moderator will be Lesley Arnold, MD, professor in the Department of Psychiatry and Behavioral Neuroscience and director of the Women’s Health Research Program. Arnold has led numerous studies on the treatment of fibromyalgia. 

Lesley Arnold, MD

Lesley Arnold, MD

Tags

Related Stories

1

Imaging reveals how a tumor-fighting drug triggers cellular breakdown

August 24, 2026

Optics trade publication SPIE highlighted research led by the University of Cincinnati's Jiajie Diao, PhD, published in Biophotonics Discovery that demonstrated how super-resolution microscopy can track how a drug alters several important structures within cancer cells.

2

UC study shows lack of awareness for lung cancer screenings across country

August 21, 2026

University of Cincinnati Cancer Center researchers have published a study in the American Journal of Surgery that found only 15% of eligible American adults have discussed lung cancer screening with their doctors.This research emphasizes the need to spread awareness and better educate the public about screening through low-dose computed tomography.